NRIX: Nurix Therapeutics, Inc. insider trading, 5% holders and institutional ownership
From public SEC filings: open-market insider purchases and sales (Form 4, last 180 days), holders of 5% or more (Schedules 13D and 13G) and institutional ownership (Form 13F). Insider and 5% data delayed 48 hours.
Insider trading
0 open-market buys totaling - and 3 sales totaling $699K in the last 180 days.
Insider sales
| Trade date | Insider | Role | Value | 10b5-1 plan |
|---|---|---|---|---|
| 2026-10-15 | Hansen Gwenn | Officer | $36K | yes |
| 2026-10-14 | Gregory Julia P | Director | $529K | |
| 2026-10-02 | Ring Christine | Officer | $134K | yes |
Activist and 5% holders
| Filed | What | Holder | Stake | Change | Filing |
|---|---|---|---|---|---|
| 2026-09-23 | New 13G stake | Perceptive Advisors LLC | 5.30% | SEC | |
| 2026-08-14 | 13G amendment | Redmile Group, LLC | 8.10% | SEC | |
| 2026-08-14 | 13G amendment | Vestal Point Capital, LP | 7.80% | SEC | |
| 2026-08-14 | New 13G stake | Rubric Capital Management LP | 6.96% | SEC | |
| 2026-08-14 | New 13G stake | T. Rowe Price Associates, Inc. | 5.30% | SEC | |
| 2026-08-14 | 13G amendment | Deep Track Capital, LP | 7.45% | SEC |
Get new insider and activist filings the morning after: daily alerts. Not investment advice.